Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.94 USD | +2.08% | -3.92% | +45.54% |
May. 10 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
May. 08 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.54% | 268M | |
+42.60% | 748B | |
+32.34% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.47% | 245B | |
+9.26% | 211B | |
-5.07% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target